Metabolic Disease
News on research and diagnostics for metabolic disorders and metabolic diseases.
Proteomics International Opens US CLIA Laboratory
The company will use the lab to run its PromarkerD proteomic blood test for identifying individuals at risk of diabetes-related chronic kidney disease.
Proteomics International Ends Licensing Deal With Sonic Health for Promarker D Test
The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.
Nadmed Raises €3.5M in Series A Funding Round
The Helsinki-based firm said that the money will support the US commercialization of its tests for nicotinamide adenine dinucleotide metabolites.
Proteomics International Inks Deal With Eurobio Scientific for French Distribution of Kidney Test
Under the terms of the five-year deal, Proteomics International will receive a payment for each of its PromarkerD diabetic kidney disease tests sold.
Metafora Biosystems Secures French National Coverage for De Vivo Disease Test
The firm's Metaglut1 test is used for the early detection of Glut1 deficiency syndrome, which causes seizures, movement disorders, and developmental delay.